Royalty Pharma is the leader in acquiring Pharmaceutical company royalties across the life sciences industry. The headquarters is in USA.
Royalty Pharma plc is a funder of biopharmaceutical industry.The company includes royalties on commercial products.
It is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry.
As on 2019, Royalty Pharma has 35 employees.
Royalty Pharma annual revenue generated for period ending Dec-2022 was 2,237 million USD.
Royalty Pharma annual net income generated for period ending Dec-2022 was 42 million USD.